Celiac Disease Screening in Patients with Diabetes

Initial Screening Timing

The American Diabetes Association recommends screening for celiac disease at the time of type 1 diabetes diagnosis, using tissue transglutaminase antibodies (tTG), and documenting normal serum IgA levels 1, 2, 3.
If IgA deficiency is present, use IgG anti-tTG and anti-deamidated gliadin antibodies instead 1, 2, 3.
The prevalence of celiac disease in patients with type 1 diabetes is significantly higher (1.6-16.4%) than in the general population (0.3-1%), justifying systematic screening 1, 3.

Repeat screening within 2 years of diabetes diagnosis, as most celiac disease cases are diagnosed within the first 5 years of type 1 diabetes diagnosis 1, 2, 3.
Perform an additional screening 5 years after initial diagnosis, as this period is critical for surveillance 1, 2, 3.

Consider more frequent screening in children with suggestive symptoms, including poor growth, increased hypoglycemia, or gastrointestinal symptoms 1, 2, 3.
More frequent screening is also recommended for children with a first-degree relative with celiac disease 1, 2.

Intestinal biopsy is recommended to confirm diagnosis in children with positive antibodies, especially if asymptomatic, before prescribing significant dietary changes 1, 2, 3.
Obtain at least 4-6 biopsy samples from the second portion of the duodenum or beyond, including the duodenal bulb 1, 2, 3.

Patients with confirmed celiac disease should be placed on a gluten-free diet 1, 2, 3.
Consultation with a dietitian experienced in managing both diabetes and celiac disease is essential, given the complexity of combined dietary restrictions 1, 2, 3.
In symptomatic children with type 1 diabetes and confirmed celiac disease, a gluten-free diet reduces symptoms and hypoglycemia rates 1, 3.
Monitor for nutritional deficiencies, including iron, folate, vitamin D, and vitamin B12 1, 2, 3.